Literature DB >> 28848900

Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis.

Marie Topp1, Jørgen Vestbo2, Erik Lykke Mortensen3.   

Abstract

Background: Understanding non-adherence in patients with chronic obstructive pulmonary disease (COPD) remains challenging. The necessity and the concerns scales of the Beliefs about Medicines Questionnaire (BMQ) are known to correlate with adherence behavior in several chronic diseases including asthma but less is known about COPD. In the present study a COPD-specific BMQ (BMQ-COPD) was translated and administered to Danish COPD outpatients. Our aim was to derive high-quality measures of the 2 dimensions included in the BMQ-COPD.
Methods: A total of 168 patients with COPD were included from a Danish respiratory outpatient clinic. The Rasch model was used to evaluate psychometric characteristics of the BMQ-COPD and to obtain necessity and concerns scales fulfilling criteria of unidimensionality and overall fit, and with all items showing individual item fit with no local dependencies, and no differential item functioning. Further, we explored the association with disease-related variables and subsequent adherence behavior.
Results: Shortened versions of the original necessity and concerns scales fitted the Rasch model and were at least as good as the original scales as predictors of adherence, although only the necessity scale was significantly associated with adherence.
Conclusion: In a Danish COPD setting high-quality measures of necessity and concerns could be derived from the BMQ-COPD. The excluded items appear to reflect other dimensions.

Entities:  

Keywords:  adherence; chronic obstructive pulmonary disease; concerns; copd; health beliefs; scale validation; unidimensionality

Year:  2016        PMID: 28848900      PMCID: PMC5556958          DOI: 10.15326/jcopdf.3.4.2016.0134

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  23 in total

1.  Item response theory and health outcomes measurement in the 21st century.

Authors:  R D Hays; L S Morales; S P Reise
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

2.  Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Maher R Khdour; Ahmed F Hawwa; Joseph C Kidney; Bronagh M Smyth; James C McElnay
Journal:  Eur J Clin Pharmacol       Date:  2012-04-05       Impact factor: 2.953

3.  Properties of the COPD assessment test in a cross-sectional European study.

Authors:  P W Jones; G Brusselle; R W Dal Negro; M Ferrer; P Kardos; M L Levy; T Perez; J J Soler Cataluña; T van der Molen; L Adamek; N Banik
Journal:  Eur Respir J       Date:  2011-05-12       Impact factor: 16.671

4.  A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation.

Authors:  Thomas Ringbaek; Gerd Martinez; Peter Lange
Journal:  COPD       Date:  2012-02       Impact factor: 2.409

5.  Concerns about medication and medication adherence in patients with chronic pain recruited from general practice.

Authors:  Benjamin A Rosser; Lance M McCracken; Sophie C Velleman; Charlotte Boichat; Christopher Eccleston
Journal:  Pain       Date:  2011-03-03       Impact factor: 6.961

6.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.

Authors:  R Horne; J Weinman
Journal:  J Psychosom Res       Date:  1999-12       Impact factor: 3.006

7.  Adherence to inhaled therapy, mortality and hospital admission in COPD.

Authors:  J Vestbo; J A Anderson; P M A Calverley; B Celli; G T Ferguson; C Jenkins; K Knobil; L R Willits; J C Yates; P W Jones
Journal:  Thorax       Date:  2009-08-23       Impact factor: 9.139

8.  Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.

Authors:  Rob Horne; Rhian Parham; Richard Driscoll; Andrew Robinson
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

9.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Authors:  Samantha S C Kon; Jane L Canavan; Sarah E Jones; Claire M Nolan; Amy L Clark; Mandy J Dickson; Brigitte M Haselden; Michael I Polkey; William D-C Man
Journal:  Lancet Respir Med       Date:  2014-02-04       Impact factor: 30.700

10.  Development and first validation of the COPD Assessment Test.

Authors:  P W Jones; G Harding; P Berry; I Wiklund; W-H Chen; N Kline Leidy
Journal:  Eur Respir J       Date:  2009-09       Impact factor: 16.671

View more
  3 in total

1.  Effect of a Multidimensional Pharmaceutical Care Intervention on Inhalation Technique in Patients with Asthma and COPD.

Authors:  Wanqing Wang; Tao Xu; Qiong Qin; Liyan Miao; Jian'an Bao; Rong Chen
Journal:  Can Respir J       Date:  2020-11-18       Impact factor: 2.409

2.  Cross-Cultural Adaptation and Lingual Validation of the Beliefs about Medicines Questionnaire (BMQ)-Specific for Cholesterol Lowering Drugs in the Visegrad Countries.

Authors:  Klára Boruzs; Viktor Dombrádi; János Sándor; Gábor Bányai; Robert Horne; Klára Bíró; Attila Nagy
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

3.  Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.

Authors:  Eng Hooi Tan; Andrea Li Ann Wong; Chuan Chien Tan; Patrick Wong; Sing Huang Tan; Li En Yvonne Ang; Siew Eng Lim; Wan Qin Chong; Jingshan Ho; Soo Chin Lee; Bee Choo Tai
Journal:  J Health Psychol       Date:  2021-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.